3 days popular7 days popular1 month popular3 months popular

Spread Of Breast Cancer Linked To Kisspeptins Which Normally Inhibit Metastasis

KISS 1 is a metastasis-suppressor gene which helps to prevent the spread of cancers, including melanoma, pancreatic and ovarian cancers to name a few. But new research from ’s Schulich School of Medicine & Dentistry shows that kisspeptins – peptide products of KISS1, actually make some worse, with a higher tumor grade and metastatic potential. The research is published online in the journal Endocrinology.

Moshmi Bhattacharya, an associate professor in the Departments of Physiology and Pharmacology, and Oncology, was surprised to find high levels of kisspeptins in aggressive breast cancers. “We found kisspeptins could turn non-invasive into invasive cells, and therefore could be playing a role in the metastasis of .”

The paper’s first author , a graduate student working with Bhattacharya, says they were also able to pinpoint what triggered to act in this unusual fashion. “Typically breast cancers are classified as being estrogen receptor-positive or estrogen receptor-negative. In estrogen receptor-negative cells we found that significantly increased invasiveness. However in cells that still expressed estrogen, does not lead to invasion,” says Cvetkovic. “We believe that estrogen is acting as a brake, and when patients lose their estrogen receptor, it allows to behave in a non-typical fashion.”

“As for clinical applications, testing to see whether the kisspeptin receptor is present or not, could provide us with an idea of whether the breast cancer will become more aggressive and thereby more metastatic,” says Bhattacharya, a New Investigator with the Canadian Institutes of Health Research (CIHR) which funded this study. She also believes kisspeptins could be a good therapeutic target.


University of Western Ontario